Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Cancer|February 28, 2007
A prospective study of the impact of nasopharyngeal cancer and radiotherapy on the psychosocial condition of Chinese patientsPeter W H Lee, Tracy T C Kwan, Dora L W Kwong, et al.
Cancer Science|June 30, 2006
Complementary activation of peripheral natural killer cell immunity in nasopharyngeal carcinomaYing Zheng, Kai-Yuan Cao, Sze Park Ng, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|April 3, 2008
Treatment outcome of rhabdomyosarcoma in Hong Kong Chinese childrenX J Yuan, Godfrey C F Chan, S K Chan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2012
A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patientsHarry C Y Cheng, Vincent W C Wu, Roger K C Ngan, et al.
Cancer Research|February 16, 2020
Epstein-Barr Virus miRNA BART2-5p Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing RND3Chen Jiang, Lei Li, Yan-Qun Xiang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 21, 2015
Post-radiation Plasma Epstein-Barr Virus DNA and Local Clinical Remission After Radical Intensity-modulated Radiation Therapy for Nasopharyngeal CarcinomaV H F Lee, D L W Kwong, T W Leung, et al.
Annals of Surgery|August 25, 2020
Neoadjuvant Chemoradiotherapy Using Cisplatin and 5-Fluorouracil (PF) Versus Carboplatin and Paclitaxel (CROSS Regimen) for Esophageal Squamous Cell Carcinoma (ESCC): A Propensity Score-matched StudyIan Y H Wong, K O Lam, Rui Qi Zhang, et al.
Plos One|June 25, 2016
Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal CarcinomaVictor H F Lee, Anthony W I Lo, Chun-Yin Leung, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Mapping the Functional Assessment of Cancer Therapy-general or -Colorectal to SF-6D in Chinese patients with colorectal neoplasmCarlos K H Wong, Cindy L K Lam, Donna Rowen, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 8, 2019
Advancing Care for Head and Neck Cancers in a Multidisciplinary Tumour Board in the EastV H F Lee, J Y W Chan, V Vardhanabhuti, et al.
Pageof 13